We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Jocelyn C. Turner
Jocelyn C. Turner
Products
PRODUCTS
Aggredyne, Inc.
Jocelyn C. Turner
Price:
$117.00
View
Seno Medical Instruments, Inc.
Richard T. Riggie
and
Jocelyn C. Turner
Price:
$117.00
View
Ultrasonic Services, Inc.
Jocelyn C. Turner
Price:
$117.00
View
Neurological Fitness Equipment and Education LLC, dba NEUFIT
Jocelyn C. Turner
Price:
$117.00
View
Curewave Lasers, LLC
Jocelyn C. Turner
Price:
$117.00
View
ANX Robotica Corp.
Jocelyn C. Turner
Price:
$117.00
View
XCATH, Inc.
Jocelyn C. Turner
Price:
$117.00
View
Forcemech International, LLC
Jocelyn C. Turner
Price:
$117.00
View
Nexalin Technology, Inc.
Jocelyn C. Turner
Price:
$117.00
View
Ramco Laboratories, Inc.
Jocelyn C. Turner
Price:
$117.00
View
View All Products by Jocelyn C. Turner
Upcoming Events
08
Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15
Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20
Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21
Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22
Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11
Oct
1st Annual Quality Management vSummit
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
AngioDynamics Gets Expanded Clearance for Auryon Atherectomy System
Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate
FDA Issues Update on Becton Dickinson’s Recall
FDA Grants Accelerated Approval to Enhertu for HER2-Mutant NSCLC
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
